According to the enterprise search APP, Zhejiang Zansheng Pharmaceutical Co., Ltd., hereinafter referred to as Zansheng Pharmaceutical, is a joint venture established by Zhejiang Haizheng Pharmaceutical Co., Ltd. and Hangzhou Gezhong Enterprise Management Consulting Center (Limited Partnership) in September 2020, with a registered capital of RMB 6,543.80 billion.
The company's main products are Tongluo Shenggu Capsule, Xiaochaihu Capsule, Gui Xiang Xiaoyao Granules, Hawthorn Chewable Tablets, Xiangtong Tablets and Xinnaoxin Tablets.